BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26390679)

  • 1. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
    Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
    J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates.
    Niebler RA; Woods KJ; Murkowski K; Ghanayem NS; Hoffman G; Mitchell ME; Punzalan RC; Scott JP; Simpson P; Tweddell JS
    Artif Organs; 2016 Jan; 40(1):80-5. PubMed ID: 26620919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
    van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
    J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass.
    Avidan MS; Levy JH; Scholz J; Delphin E; Rosseel PM; Howie MB; Gratz I; Bush CR; Skubas N; Aldea GS; Licina M; Bonfiglio LJ; Kajdasz DK; Ott E; Despotis GJ
    Anesthesiology; 2005 Feb; 102(2):276-84. PubMed ID: 15681940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome.
    Svenmarker S; Häggmark S; Jansson E; Lindholm R; Appelblad M; Sandström E; Aberg T
    Scand Cardiovasc J; 2002 Aug; 36(4):241-6. PubMed ID: 12201973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery.
    Spiess BD; Vocelka C; Cochran RP; Soltow L; Chandler WL
    J Cardiothorac Vasc Anesth; 1998 Jun; 12(3):299-304. PubMed ID: 9636912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?
    Mahmood S; Bilal H; Zaman M; Tang A
    Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):406-14. PubMed ID: 22228288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model.
    Berry LR; Thong B; Chan AK
    Thromb Haemost; 2009 Aug; 102(2):302-8. PubMed ID: 19652880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M
    Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial antithrombin-III deficiency during cardiopulmonary bypass: a case report.
    Brinks HJ; Weerwind PW; Verkroost MW; Nováková I; Brouwer MH
    Perfusion; 2000 Nov; 15(6):553-6. PubMed ID: 11131221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
    Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I
    Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
    Borowiec J; Bagge L; Saldeen T; Thelin S
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data.
    Paidas MJ; Triche EW; James AH; DeSancho M; Robinson C; Lazarchick J; Ornaghi S; Frieling J
    Am J Perinatol; 2016 Mar; 33(4):343-9. PubMed ID: 26461927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy.
    Paidas MJ; Forsyth C; Quéré I; Rodger M; Frieling JT; Tait RC;
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):444-50. PubMed ID: 24686101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable biocompatibility of Phisio- and Bioline-coated cardiopulmonary bypass circuits indicated by the inflammatory response.
    Thiara AS; Andersen VY; Videm V; Mollnes TE; Svennevig K; Hoel TN; Fiane AE
    Perfusion; 2010 Jan; 25(1):9-16. PubMed ID: 20172900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.